Mechanisms of cancer cell death induction by paclitaxel: an updated review
S Zhao, Y Tang, R Wang, M Najafi - Apoptosis, 2022 - Springer
Chemoresistance of cancer cells is a major problem in treating cancer. Knowledge of how
cancer cells may die or resist cancer drugs is critical to providing certain strategies to …
cancer cells may die or resist cancer drugs is critical to providing certain strategies to …
Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects
Dealing with cancer is of importance due to enhanced incidence rate of this life-threatening
disorder. Chemotherapy is an ideal candidate in overcoming and eradication of cancer. To …
disorder. Chemotherapy is an ideal candidate in overcoming and eradication of cancer. To …
Curcumin as an enhancer of therapeutic efficiency of chemotherapy drugs in breast cancer
R Farghadani, R Naidu - International Journal of Molecular Sciences, 2022 - mdpi.com
Female breast cancer is the world's most prevalent cancer in 2020. Chemotherapy still
remains a backbone in breast cancer therapy and is crucial in advanced and metastatic …
remains a backbone in breast cancer therapy and is crucial in advanced and metastatic …
Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects
The efficacy of chemotherapy in cancer therapy is limited due to resistance, treatment
selectivity, and severe adverse effects. Immunotherapy, chemotherapy, targeted therapy …
selectivity, and severe adverse effects. Immunotherapy, chemotherapy, targeted therapy …
Curcumin-and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on HCT116 colorectal cancer model
Combination chemotherapy, administrating two chemotherapeutic agents concurrently,
comes into prominence, as the heterogeneity or the level of the disease necessitates a …
comes into prominence, as the heterogeneity or the level of the disease necessitates a …
[HTML][HTML] Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind …
T Saghatelyan, A Tananyan, N Janoyan, A Tadevosyan… - Phytomedicine, 2020 - Elsevier
Background: The clinical efficacy of curcumin has not yet been established for the treatment
of cancer, despite a large body of evidence from numerous preclinical studies suggesting …
of cancer, despite a large body of evidence from numerous preclinical studies suggesting …
Curcumin: modulator of key molecular signaling pathways in hormone-independent breast cancer
R Farghadani, R Naidu - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer remains the most commonly diagnosed cancer and the
leading cause of cancer death among females worldwide. It is a highly heterogeneous …
leading cause of cancer death among females worldwide. It is a highly heterogeneous …
[PDF][PDF] Curcumin and its derivatives: A review of their biological activities
Since the dawn of humankind, natural products have been widely used as a medicine for the
management of a wide range of diseases that affected the human health (1). Natural product …
management of a wide range of diseases that affected the human health (1). Natural product …
Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo
C Pi, W Zhao, M Zeng, J Yuan, H Shen, K Li, Z Su… - Drug Delivery, 2022 - Taylor & Francis
The main aim of this study was to improve the therapeutic potential of a paclitaxel (PTX) and
curcumin (CU) combination regimen using solid lipid nanoparticles (SLNs). PTX and CU …
curcumin (CU) combination regimen using solid lipid nanoparticles (SLNs). PTX and CU …
Co-delivery of curcumin and paclitaxel by “core-shell” targeting amphiphilic copolymer to reverse resistance in the treatment of ovarian cancer
MD Zhao, JQ Li, FY Chen, W Dong… - International journal …, 2019 - Taylor & Francis
Background Ovarian cancer is a common malignancy in the female reproductive system with
a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer …
a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer …